ArticleHuman brain mapping2026
Investigating Emotional Reactivity in Experienced Users of Psychedelics: A Cross-Sectional fMRI Study.
Article in Human brain mapping, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
Classic psychedelics profoundly alter emotional states, inducing intense acute experiences lasting hours, followed by subtler, longer-lasting changes in emotional reactivity that can persist for weeks. While experimental and clinical studies document these prolonged effects, the highly context-dependent nature of psychedelic experiences leaves open the question of whether naturalistic, nonclinical use similarly modulates emotional processing. To investigate this, we conducted a preregistered, cross-sectional fMRI study comparing experienced psychedelic users (≥ 10 lifetime uses; N = 33) with closely matched nonusers (N = 34). Participants performed an emotional face recognition task, and we examined behavioral performance and neural responses to angry, happy, and fearful facial expressions. Behavioral results revealed that psychedelic users recognized angry expressions more quickly and accurately, indicating enhanced processing efficiency for threat-related stimuli. Consistent with this, whole-brain fMRI analyses showed reduced activation to anger in key limbic and salience network regions. Psychedelic users also exhibited heightened responses to happy expressions in parietal and sensorimotor cortices-aligning with prior clinical observations-as well as increased precuneus activation to fearful expressions. Region-of-interest analyses further demonstrated reduced differentiation between emotional categories in two default mode network nodes: the frontal medial cortex and parahippocampal gyrus. These findings provide a nuanced characterization of neurofunctional changes in emotional processing linked to repeated naturalistic psychedelic use. By bridging clinical and real-world contexts, this work deepens our understanding of the potential long-term consequences of psychedelics and complements existing evidence from controlled therapeutic settings.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.